Jun 09, 2017
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $13.17 to $0.88.
The split itself did not change the total investment value.
Citius Pharmaceuticals, Inc. (CTXR) trades on the NASDAQ Capital Market in the Biotechnology industry.
Citius Pharmaceuticals, Inc. company overviewThe latest split shown was on June 9, 2017. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records one reverse split, on June 9, 2017.